Abstract
Glucocorticoid regulation of nicotine sensitivity was investigated in adrenalectomized (ADX) and sham-operated C3H mice administered chronic corticosterone (CCS) replacement therapy. Hormone pellets (60% CCS or pure cholesterol) were implanted at the time of surgery and animals were tested for nicotine sensitivity in a battery of behavioral and physiological tests. ADX-induced increases in nicotine sensitivity were reversed by chronic CCS replacement. Sham-operated animals that received CCS supplementation were subsensitive to the effects of nicotine. In both ADX and sham-operated animals, chronic CCS administration induced a decrease in the number of CNS nicotinic cholinergic receptors labeled by alpha-[125I]-bungarotoxin. Binding was decreased by 30–60% depending on brain region; no changes in affinity (K d ) were detected. The number of brain nicotinic sites labeled by [3H]-nicotine was unaltered following 1 week of chronic CCS administration. These data support the hypothesis that glucocorticoids modulate nicotine sensitivity in the C3H mouse. In animals chronically treated with CCS, nicotine tolerance may be due to CCS-induced changes in nicotinic cholinergic receptor binding or the presence of high CCS titers at the time of testing.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Biegon A, Rainbow TC, McEwen BS (1985) Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiography study. Brain Res 332:309–314
Cam GR, Bassett JR (1983) The effect of acute nicotine administration on plasma levels of the thyroid hormones and corticosterone in the rat. Pharmacol Biochem Behav 19:559–561
Davies AO, Lefkowitz RJ (1984) Regulation of B-adrenergic receptors by steroid hormones. Annu Rev Physiol 46:119–130
De Kloet ER, Veldhuis HD (1985) Adrenocortical hormone action. In: Lejtha A (ed) Handbook of neurochemistry, vol. 8. Plenum Press, New York
De Kloet ER, Ratka A, Reul JMHM, Sutanto W, Van Eekelen JAM (1987) Corticosteroid receptor types in brain: regulation and putative function. Ann NY Acad Sci 512:351–361
Fatranska M, Budai D, Gulya K, Kuetnansky R (1989) Changes in acetylcholine content, release and muscarinic receptors in rat hippocampus under cold stress. Life Sci 45:143–149
Freund RK, Martin BJ, Jungschaffer DA, Ullman EA, Collins AC (1988) Genetic differences in plasma corticosterone levels in response to nicotine injection. Pharmacol Biochem Behav 30:1059–1064
Gilad GM, Rabey JM, Gilad VH (1987) Presynpatic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interaction in stress. Life Sci 40:2401–2408
Gwosdow-Cohen A, Chen CL, Besch EL (1982) Radioimmunoassay of serum corticosterone in rats. Proc Soc Exp Biol Med 170:29–34
Halpain S, McEwen BS (1988) Corticosterone decreases3H-glutamate binding in rat hippocampal formation. Neuroendocrinology 48:235–241
Imperato A, Puglisi-Allegra S, Casolini P, Zocchi A, Angelucci L (1989) Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. Eur J Pharmacol 165:337–338
Kendall DA, McEwen BS, Enna SJ (1982) The influence of ACTH and corticosterone on [3H] GABA receptor binding in rat brain. Brain Res 236:365–374
Lowry OH, Rosebrough NH, Farr AC, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Majewska MD, Bisserbe JC, Eskay RL (1985) Glucocorticoids are modulators of GABAA receptors in brain. Brain Res 339:178–182
Marks MJ, Collins AC (1982) Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol 22:554–564
Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817–825
Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619–628
Marks MJ, Romm E, Gaffney DK, Collins AC (1986a) Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther 237:809–819
Marks MJ, Stitzel JA, Collins AC (1986b) Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. J Pharmacol Exp Ther 239:358–364
Martin BJ, Wehner JM (1988) Influence of genotype on nicotine-induced increases of plasma corticosterone in mice as a result of acute nicotine pretreatment. Pharmacol Biochem Behav 30:1065–1070
Meyer JS, Micco DJ, Stephenson BS, Krey LC, McEwen BS (1979) Subcutaneous implantation method for chronic glucocorticoid replacement therapy. Physiol Behav 22:867–870
Pauly JR, Ullman EA, Collins AC (1988) Adrenocortical hormone regulation of nicotine sensitivity in mice. Physiol Behav 44:109–116
Pauly JR, Ullman EA, Collins AC (1990) Strain differences in adrenalectomy-induced alterations in nicotine sensitivity in the mouse. Pharmacol Biochem Behav 35:171–179
Pomerleau OF, Pomerleau CS (1984) Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation. Neurosci Biobehav Rev 8:503–513
Reul JMHM, De Kloet ER (1986) Anatomical resolution of two types of corticosterone receptor sites in rat brain with in vitro autoradiography and computerized image analysis. J Steroid Biochem 24:269–272
Riker DK, Sastre A, Baker T, Both RH, Riker WF (1979) Regional high-affinity [3H] choline accumulation in cat forebrain: selective increase in the caudate putamen after corticosteroid pretreatment. Mol Pharmacol 16:886–899
Riker WF, Baker T, Sastre A (1982) Electrophysiologic and clinical aspects of glucocorticoids on certain neural systems. In: Ganten D, Pfaff D (eds) Current topics in neuroendocrinology. Springer, Berlin Heidelberg New York
Romano C, Goldstein A (1980) Stereospecific nicotine receptors on rat brain membranes. Science 210:647–650
Rose JE, Ananda S, Jarvik ME (1983) Cigarette smoking during anxiety-provoking and monotonous tasks. Addict Behav 8:353–359
Schachter S, Silverstein B, Kozlowski LT, Herman CP, Liebling B (1977) Effects of stress on cigarette smoking and urinary pH. J Exp Psychol 106:24–30
Schiffman S (1989) Tobacco “chippers” — individual differences in tobacco dependence. Psychopharmacology 97:539–547
Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214–216
Schwartz RD, Kellar KJ (1985) In vivo regulation of [3H] acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427–433
Stolerman IP, Fink R, Jarvik ME (1973) Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacologia 30:329–342
Stolerman IP, Bunker P, Jarvik ME (1974) Nicotine tolerance in rats; role of dose and dose interval. Psychopharmacologia 34:317–324
Wilkins JN, Carlson HE, Vanakis HV, Hill MA, Gritz E, Jarvik ME (1982) Nicotine from cigarette smoking increases in circulating levels of cortisol, growth hormone and prolactin in male chronic smokers. Psychopharmacology 78:305–308
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pauly, J.R., Grün, E.U. & Collins, A.C. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice. Psychopharmacology 101, 310–316 (1990). https://doi.org/10.1007/BF02244047
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244047